Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

48.54
BATS BZX Real-Time Price
As of 12:11pm ET
 +0.47 / +0.98%
Today’s Change
31.25
Today|||52-Week Range
58.46
-14.19%
Year-to-Date
Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium
May 23 / TheStreet.com - Paid Partner Content
Strong On High Volume: Neurocrine Biosciences (NBIX)
May 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close48.07
Today’s open48.55
Day’s range48.33 - 49.13
Volume13,861
Average volume (3 months)1,256,841
Market cap$4.2B
Dividend yield--
Data as of 12:11pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-85.83%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book9.77

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.18+1.18%
ACADACADIA Pharmaceutica...+0.64+1.87%
ANACAnacor Pharmaceutica...+0.04+0.04%
AKRXAkorn Inc+0.37+1.21%
Data as of 12:15pm ET, 05/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs